Unregulated DIY injections rise as users bypass medical safety standards

A growing trend of unregulated self-injections is emerging as individuals use products marketed for “research use only” or sourced from overseas websites to bypass medical regulations. These products include peptides such as BPC-157 and TB-500, as well as botulinum toxins and dermal fillers.

Vendors often use “research use only” labels as a legal disclaimer to avoid the manufacturing, testing, and labeling obligations required for medicines. Consequently, there is no federal verification of the purity, potency, or sterility of these substances. The FDA has issued warning letters to producers regarding sterility violations and has placed some firms on import alerts due to failures in testing ingredients for quality and contamination.

In the cosmetic sector, influencers are increasingly vlogging step-by-step tutorials on self-injecting neurotoxins and fillers purchased from international websites, often claiming to be based in South Korea. While these substances are restricted to licensed medical professionals in the United States due to safety risks, they remain accessible online, leading to reports of adverse events such as redness and swelling at injection sites.